| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 24 Aug 2026 | 28 May 2026 |
| The Board of Directors have approved the notice of the 83rd Annual General Meeting AGM of the Company to be held on Monday 24th August 2026 through Video Conference Other Audio Visual Means VC OAVM BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Corrigendum to Notice of the 83rd Annual General Meeting. (As Per NSE Announcement Dated On : 10.08.2026) Balaxi Pharmaceuticals Limited has informed the Exchange regarding Notice of 83rd Annual General Meeting to be held on 24th August, 2026. (As Per NSE Announcement Dated On : 31.07.2026 BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Proceedings of the 83rd Annual General Meeting held on 24th August, 2026 BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers Report of Annual General Meeting held on 24th August, 2026. Further, the company has informed the Exchange regarding Voting Results. As Per NSE Announcement Dated On : 24.08.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
